Elan Ezickson Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Elan Ezickson.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Elan Ezickson. Elan Ezickson is Director in ZIOPHARM ONCOLOGY INC ($ZIOP) and Director in MARINUS PHARMACEUTICALS INC ($MRNS) and Chief Business Officer in AVEO PHARMACEUTICALS INC ($AVEO) and Chief Operating Officer in AVEO PHARMACEUTICALS INC ($AVEO) and COO & Head of Corp.Development in Scholar Rock Holding Corp ($SRRK).
Latest Insider Trading Transactions of Elan Ezickson
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AVEO, MRNS, SRRK, ZIOP
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 19 2021 | MRNS | MARINUS PHARMACEUT ... | Ezickson Elan | Director | Option Exercise | A | 12.60 | 16,500 | 207,900 | 16,500 | |
Jan 03 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | Ezickson Elan | Director | Payment of Exercise | F | 4.72 | 40,107 | 189,305 | 71,887 | 112 K to 71.9 K (-35.81 %) |
Jan 03 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | Ezickson Elan | Director | Grant | A | 0.00 | 31,780 | 0 | 111,994 | 80.2 K to 112 K (+39.62 %) |
Dec 13 2019 | MRNS | MARINUS PHARMACEUT ... | Ezickson Elan | Director | Option Exercise | A | 1.78 | 100,000 | 178,000 | 100,000 | |
Jan 02 2019 | ZIOP | ZIOPHARM ONCOLOGY ... | Ezickson Elan | Director | Grant | A | 0.00 | 80,214 | 0 | 80,214 | 0 to 80.2 K |
Sep 20 2018 | ZIOP | ZIOPHARM ONCOLOGY ... | Ezickson Elan | Director | Option Exercise | A | 3.00 | 50,000 | 150,000 | 50,000 | |
May 31 2018 | SRRK | Scholar Rock Holdi ... | Ezickson Elan | COO & Head of Corp. ... | Option Exercise | A | 5.77 | 8,757 | 50,528 | 8,757 | |
May 31 2018 | SRRK | Scholar Rock Holdi ... | Ezickson Elan | COO & Head of Corp. ... | Option Exercise | A | 5.77 | 8,757 | 50,528 | 8,757 | |
Jan 28 2013 | AVEO | AVEO PHARMACEUTICA ... | Ezickson Elan | Chief Operating Off ... | Option Exercise | A | 7.72 | 37,500 | 289,500 | 37,500 | |
Jan 28 2013 | AVEO | AVEO PHARMACEUTICA ... | Ezickson Elan | Chief Operating Off ... | Sell | S | 7.77 | 1,150 | 8,937 | 61,843 | 63 K to 61.8 K (-1.83 %) |
Jan 28 2013 | AVEO | AVEO PHARMACEUTICA ... | Ezickson Elan | Chief Operating Off ... | Grant | A | 0.00 | 37,500 | 0 | 62,993 | 25.5 K to 63 K (+147.10 %) |
Feb 02 2012 | AVEO | AVEO PHARMACEUTICA ... | Ezickson Elan | Chief Business Offi ... | Option Exercise | A | 13.18 | 35,100 | 462,618 | 35,100 | |
Feb 02 2012 | AVEO | AVEO PHARMACEUTICA ... | Ezickson Elan | Chief Business Offi ... | Grant | A | 0.00 | 20,600 | 0 | 25,493 | 4.9 K to 25.5 K (+421.01 %) |
Jan 30 2012 | AVEO | AVEO PHARMACEUTICA ... | Ezickson Elan | Chief Business Offi ... | Sell | S | 13.37 | 1,107 | 14,796 | 4,893 | 6 K to 4.9 K (-18.45 %) |
Jun 14 2011 | AVEO | AVEO PHARMACEUTICA ... | Ezickson Elan | Chief Business Offi ... | Sell | S | 18.73 | 10,000 | 187,306 | 6,000 | 16 K to 6 K (-62.50 %) |
May 17 2011 | AVEO | AVEO PHARMACEUTICA ... | Ezickson Elan | Chief Business Offi ... | Sell | S | 18.08 | 10,000 | 180,774 | 16,000 | 26 K to 16 K (-38.46 %) |
Apr 13 2011 | AVEO | AVEO PHARMACEUTICA ... | Ezickson Elan | Chief Business Offi ... | Sell | S | 13.63 | 10,000 | 136,270 | 26,000 | 36 K to 26 K (-27.78 %) |
Mar 18 2011 | AVEO | AVEO PHARMACEUTICA ... | Ezickson Elan | Chief Business Offi ... | Sell | S | 14.42 | 7,500 | 108,131 | 36,000 | 43.5 K to 36 K (-17.24 %) |
Feb 23 2011 | AVEO | AVEO PHARMACEUTICA ... | Ezickson Elan | Chief Business Offi ... | Option Exercise | M | 1.32 | 5,000 | 6,600 | 37,500 | |
Feb 23 2011 | AVEO | AVEO PHARMACEUTICA ... | Ezickson Elan | Chief Business Offi ... | Sell | S | 13.85 | 5,000 | 69,265 | 11,000 | 16 K to 11 K (-31.25 %) |
Feb 23 2011 | AVEO | AVEO PHARMACEUTICA ... | Ezickson Elan | Chief Business Offi ... | Buy | M | 1.32 | 5,000 | 6,600 | 16,000 | 11 K to 16 K (+45.45 %) |
Feb 17 2011 | AVEO | AVEO PHARMACEUTICA ... | Ezickson Elan | Chief Business Offi ... | Option Exercise | A | 14.16 | 17,500 | 247,800 | 17,500 | |
Feb 17 2011 | AVEO | AVEO PHARMACEUTICA ... | Ezickson Elan | Chief Business Offi ... | Option Exercise | A | 12.24 | 16,250 | 198,900 | 16,250 | |
Feb 17 2011 | AVEO | AVEO PHARMACEUTICA ... | Ezickson Elan | Chief Business Offi ... | Grant | A | 0.00 | 6,000 | 0 | 11,000 | 5 K to 11 K (+120.00 %) |
Jan 13 2011 | AVEO | AVEO PHARMACEUTICA ... | Ezickson Elan | Chief Business Offi ... | Option Exercise | M | 1.32 | 5,000 | 6,600 | 42,500 | |
Jan 13 2011 | AVEO | AVEO PHARMACEUTICA ... | Ezickson Elan | Chief Business Offi ... | Sell | S | 14.77 | 5,000 | 73,874 | 5,000 | 10 K to 5 K (-50.00 %) |
Jan 13 2011 | AVEO | AVEO PHARMACEUTICA ... | Ezickson Elan | Chief Business Offi ... | Buy | M | 1.32 | 5,000 | 6,600 | 5,000 | 0 to 5 K |
Dec 13 2010 | AVEO | AVEO PHARMACEUTICA ... | Ezickson Elan | Chief Business Offi ... | Option Exercise | M | 1.32 | 2,500 | 3,300 | 47,500 | |
Dec 13 2010 | AVEO | AVEO PHARMACEUTICA ... | Ezickson Elan | Chief Business Offi ... | Sell | S | 14.28 | 2,500 | 35,698 | 0 | 2.5 K to 0 (-100.00 %) |
Dec 13 2010 | AVEO | AVEO PHARMACEUTICA ... | Ezickson Elan | Chief Business Offi ... | Buy | M | 1.32 | 2,500 | 3,300 | 2,500 | 0 to 2.5 K |
Dec 13 2010 | AVEO | AVEO PHARMACEUTICA ... | Ezickson Elan | Chief Business Offi ... | Sell | S | 14.28 | 2,500 | 35,698 | 37,500 | 40 K to 37.5 K (-6.25 %) |
Nov 12 2010 | AVEO | AVEO PHARMACEUTICA ... | Ezickson Elan | Chief Business Offi ... | Sell | S | 16.33 | 5,000 | 81,650 | 40,000 | 45 K to 40 K (-11.11 %) |
Oct 05 2010 | AVEO | AVEO PHARMACEUTICA ... | Ezickson Elan | Chief Business Offi ... | Sell | S | 13.07 | 5,000 | 65,330 | 45,000 | 50 K to 45 K (-10.00 %) |
Mar 17 2010 | AVEO | AVEO PHARMACEUTICA ... | Ezickson Elan | Chief Business Offi ... | Option Exercise | M | 0.48 | 37,500 | 18,000 | 0 | |
Mar 17 2010 | AVEO | AVEO PHARMACEUTICA ... | Ezickson Elan | Chief Business Offi ... | Buy | M | 0.48 | 37,500 | 18,000 | 50,000 | 12.5 K to 50 K (+300.00 %) |
Page: 1